SCHEMBL20172646

SCHEMBL20172646

Cc1ccc(-c2cc(C)c3oc(=O)n(C)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSC P53634 1/20 0.41
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
TSHR P16473 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PKM P14618 2/20 0.37
KMT2A Q03164 1/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2B P29275 2/20 0.35
ADORA2A P29274 1/20 0.35
NOTUM Q6P988 1/20 0.35
HSD11B1 P28845 1/20 0.35
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19592149 0.85 CTSC (0.45) CTSCTSHRALDH1A1CYP1A2PKM
SCHEMBL19362764 0.80 PKM (0.39) CSNK2A2CSNK2BCSNK2A1TSHRALDH1A1
SCHEMBL20172639 0.78 GPR55 (0.46) ALDH1A1PKMKMT2AADORA3HSD11B1
SCHEMBL17766366 0.74 IL2 (0.55) KMT2AHTTSMN1; SMN2
SCHEMBL16362080 0.73 HSD17B10 (0.35) CTSCTSHRKDM4EALDH1A1HSD17B10
SCHEMBL30538040 0.73 AHR (0.37) TSHRKDM4EALDH1A1HSD17B10PKM
SCHEMBL30445159 0.73 HSD17B10 (0.35) CTSCTSHRKDM4EALDH1A1HSD17B10
SCHEMBL4869474 0.73 PKM (0.33) CTSCTSHRKDM4EALDH1A1PKM
SCHEMBL19360279 0.71 PPARG (0.39) CTSCALDH1A1PKMKMT2A
SCHEMBL14867215 0.69 ASAH1 (0.42) KDM4EALDH1A1PKMKMT2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3323814-B1 (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS ASTRAZENECA AB (SE) 2020-05-13 EP disclosed
EP-3323814-A1 (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS AstraZeneca AB (SE) 2018-05-23 EP disclosed